Evaluation of salmeterol or montelukast as second-line therapy for asthma not controlled with inhaled corticosteroids. [electronic resource]
Producer: 20010503Description: 1021-6 p. digitalISSN:- 0012-3692
- Acetates -- therapeutic use
- Adenosine Monophosphate
- Administration, Inhalation
- Administration, Topical
- Adrenergic beta-Agonists -- administration & dosage
- Adult
- Albuterol -- analogs & derivatives
- Anti-Asthmatic Agents -- administration & dosage
- Anti-Inflammatory Agents -- administration & dosage
- Asthma -- drug therapy
- Breath Tests
- Bronchial Provocation Tests
- Bronchodilator Agents -- therapeutic use
- Cross-Over Studies
- Cyclopropanes
- Eosinophils
- Female
- Glucocorticoids
- Humans
- Leukocyte Count
- Leukotriene Antagonists -- administration & dosage
- Male
- Nitric Oxide -- analysis
- Peak Expiratory Flow Rate
- Quinolines -- therapeutic use
- Respiratory Mechanics
- Salmeterol Xinafoate
- Single-Blind Method
- Steroids
- Sulfides
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.